Starnberg, Germany

Robert Purrman


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 1979

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert Purrman

Introduction

Robert Purrman is a notable inventor located in Starnberg, Germany, recognized for his contributions to the field of polymer chemistry. With a focus on aziridine compounds, Purrman has made significant strides in polymerization processes, which have implications for various industrial applications.

Latest Patents

Purrman's most significant patent is centered on a novel polymerization process for aziridine compounds. This process involves mixing an aziridine compound with a polymerization initiator described by a specific formula that includes an alkyl radical of 1 to 18 carbon atoms. This innovation not only enhances the efficiency of polymerization but also expands the potential uses of aziridine compounds in various sectors.

Career Highlights

Robert Purrman has achieved recognition within his professional realm, particularly for his groundbreaking patent related to polymerization. He is actively engaged in his role at the company Espe, Fabrik Pharmazeutischer Präparate GmbH, where he continues to explore advancements in pharmaceutical preparations. His dedication to innovation has paved the way for new methodologies in the chemical industry.

Collaborations

Throughout his career, Purrman has collaborated with esteemed professionals, including Werner Schmitt and Peter Jochum. These partnerships have fostered an environment of innovation and creativity, enabling the development of groundbreaking techniques and products in polymer chemistry.

Conclusion

Robert Purrman's contributions to the field of polymerization are notable, particularly with his pioneering work on aziridine compounds. His patent signifies not only a personal achievement but also a crucial advancement in the chemical industry. As he continues to work with his colleagues at Espe, Fabrik Pharmazeutischer Präparate GmbH, the potential for future innovations remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…